LARP1 抗体 (AA 575-625)
-
- 抗原 See all LARP1 抗体
- LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))
-
抗原表位
- AA 575-625
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This LARP1 antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunofluorescence (IF), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- 特异性
- Region between residue 575 and 625 of human La ribonucleoprotein domain family, member 1 using the numbering given in entry NP_291029.2 (GeneID 23367).
- 纯化方法
- Immunoaffinity purified
- 亚型
- IgG
- Top Product
- Discover our top product LARP1 Primary Antibody
-
-
- 应用备注
-
Approved: IF (1:50 - 1:250), IHC, IHC-P (1:100 - 1:500), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Colon Carcinoma, Ovarian Carcinoma. - 说明
-
Target Species of Antibody: Human
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- Lot specific
- 缓冲液
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- 4 °C
- 储存方法
- Store at 2-8°C for up to 1 year.
- 有效期
- 12 months
-
- 抗原
- LARP1 (La Ribonucleoprotein Domain Family, Member 1 (LARP1))
- 别名
- LARP1 / La-Related Protein 1 (LARP1 产品)
- 别名
- RGD1306683 antibody, wu:fb92d03 antibody, wu:fd15e07 antibody, 3110040D16RIK antibody, MGC98945 antibody, LARP antibody, 1810024J12Rik antibody, 3110040D16Rik antibody, Larp antibody, mKIAA0731 antibody, La ribonucleoprotein domain family, member 1 antibody, La ribonucleoprotein domain family member 1 antibody, La ribonucleoprotein domain family member 1 L homeolog antibody, Larp1 antibody, larp1 antibody, LARP1 antibody, larp1.L antibody
- 背景
-
Name/Gene ID: LARP1
Synonyms: LARP1, La-related protein 1, LARP, KIAA0731 - 基因ID
- 23367
- 途径
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-